Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Solid Biosciences Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 78 | −3 |
| Shares | 75.6M | 200 | 69.3M | −6.25M (−8.3%) |
| Value | $132.2M | $0 | $83.3M | −$48.9M (−37.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Solid Biosciences Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirabella Financial Services LLP | 65,100 | $78.0K | 0.01% |
| State of Wyoming | 51,538 | $62.0K | 0.03% |
| Russell Investments Group, Ltd. | 28,275 | $33.0K | 0.00% |
| Engineers Gate Manager LP | 11,395 | $14.0K | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $12.0K | 0.01% |
| Amalgamated Bank | 7,178 | $9.00K | 0.00% |
| Amalgamated Financial Corp. | 7,178 | $9.00K | 0.00% |
| Meeder Asset Management Inc | 6,036 | $7.00K | 0.00% |
| Captrust Financial Advisors | 3,816 | $5.00K | 0.00% |
| Laurel Wealth Advisors LLC | 2,000 | $2.00K | 0.00% |
| Parallel Advisors, LLC | 100 | $0 | 0.00% |
Sold out (14)
Institutions that held Solid Biosciences Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Nomura Holdings Inc | 268,709 | $470.0K |
| Caxton Associates LP | 177,571 | $311.0K |
| Acadian Asset Management LLC | 123,406 | $214.0K |
| Panagora Asset Management Inc | 121,797 | $213.0K |
| Gsa Capital Partners LLP | 113,104 | $198.0K |
| ExodusPoint Capital Management, LP | 64,086 | $112.0K |
| Bailard, Inc. | 53,400 | $93.0K |
| Assenagon Asset Management S.A. | 25,893 | $45.0K |
| Cubist Systematic Strategies, LLC | 18,715 | $33.0K |
| SG Americas Securities, LLC | 16,870 | $30.0K |
| Two Sigma Securities, LLC | 11,425 | $20.0K |
| Chicago Partners Investment Group LLC | 18,993 | $20.0K |
| JNBA Financial Advisors | 8,000 | $14.0K |
| Ellevest, Inc. | 163 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Solid Biosciences Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Reilly Financial Advisors, LLC | 200 | $0 |